Evidence map›Paper›PMID 34815800›Full record

ArticleTheranostics2021

Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.

Lifeng Hang, Tao Zhang, Hua Wen, Meng Li, Lianbao Liang, Xinfeng Tang, Chunze Zhou, JunZhang Tian, Xiaofen Ma, Guihua Jiang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.International journal of nanomedicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lifeng HangThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Tao ZhangKey Laboratory of Materials Physics, Institute of Solid State Physics, HFIPS, Chinese Academy of Sciences, Hefei, 230031, P. R. China.
Hua WenThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Meng LiThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Lianbao LiangThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Xinfeng TangDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, University of Science and Technology of China, Hefei, 230001, P. R. China.
Chunze ZhouInterventional Radiology Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, P. R. China.
JunZhang TianThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Xiaofen MaThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Guihua JiangThe Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. China.
Guangdong Provincial People's Hospital · CNInstitute of Solid State Physics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiomimeticsCell Line, TumorChinaCombined Modality TherapyFemaleGlucose OxidaseHydrogen-Ion ConcentrationMiceNanoparticle Drug Delivery SystemNanoparticlesNanotechnologyNeoplasmsTirapazamineTumor MicroenvironmentXenograft Model Antitumor AssaysGlucose OxidaseNanoparticle Drug Delivery SystemTirapazaminebiocatalytic nanoreactorGlucose oxidasemetal-organic frameworkstarvation therapytirapazamine

Identifiers

PMID34815800
PMCPMC8581412
OpenAlexW3208315833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.